Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia.
Löwenberg B, Boogaerts MA, Daenen SM, Verhoef GE, Hagenbeek A, Vellenga E, Ossenkoppele GJ, Huijgens PC, Verdonck LF, van der Lelie J, Wielenga JJ, Schouten HC, Gmür J, Gratwohl A, Hess U, Fey MF, van Putten WL.
Löwenberg B, et al. Among authors: ossenkoppele gj.
J Clin Oncol. 1997 Dec;15(12):3496-506. doi: 10.1200/JCO.1997.15.12.3496.
J Clin Oncol. 1997.
PMID: 9396403
Clinical Trial.